AlphAIAlphAI — Financial news for AI agents
stocktitan.netSEP 292 min read$CNXC

Concentrix reported a $988 million loss, while operations provided $268 million in cash.

Concentrix (CNXC) reported a Q3 2026 net loss of $988.1M, including a $1.05B non-cash goodwill impairment charge. Revenue fell 1.2% YoY to $2.45B. Non-GAAP EPS rose 5% to $2.92. Operating cash flow was $268.2M. The dividend increased to $0.37 per share. Full-year revenue guidance is $9.83B-$9.88B, with an expected operating loss of $512M-$522M.

Original reporting
stocktitan.net
Published Sep 29, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CNXC
Bearish
high confidence
Mentioned
$CNXC
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CNXCBearishMed
01

Why it matters

The earnings miss and impairment are likely to drive short-term selling pressure.

02

Market read

First‑report earnings release with material loss; traders may adjust positions today.

03

What to watch

Non‑GAAP earnings beat and modest free cash flow generation may soften the impact.

Relevance 8/10Novelty 9/10Timing: today

Background

Concentrix reported Q3 2026 results with a sizable net loss and a $1.05B goodwill impairment.

Company-level read

Ticker impact

$CNXCBearishHigh confidence
Context

Q3 2026 net loss of $988.1M and 1.2% revenue decline disclosed, with guidance for FY loss and lower revenue.

Expected impact

likely downside as market prices in the loss and impairment.

Evidence & confidence

The surprise loss and $1.05B goodwill charge are material and new, prompting sell pressure.

Market effects

Sector

Technology services sector may see broader scrutiny of profit margins.

Regional

U.S. market participants may adjust exposure to outsourcing firms.

Global

Limited to investors tracking US-listed BPO companies.

Counterpoint

What could challenge this read

The dividend increase could signal confidence in cash flow despite the loss.

Key entities

  • company
    Concentrix Corporation

    US‑listed technology and services provider (NASDAQ: CNXC).

Read at source← All news

Also covered by

1 outlet

Related articles

SEP 30
$CNXCHighAI 8/10

Concentrix earnings analysis: questions answered and next catalysts

Concentrix Corp (CNXC) reported Q3 earnings with a $0.21 EPS beat ($2.92) but a $30M revenue miss ($2.45B vs. $2.48B est). Shares initially dropped 9.77% before recovering 3.12%. Management highlighted AI-driven revenue growth (50% of total) and cash flow strength ($218M), but revenue declines due to specific client exits and offshoring. The dividend was raised to $0.37/share. Growth is expected to return in 2028, with key catalysts including Q4 earnings and debt paydown milestones.

investing.com2 min
SEP 30
$CNXCMedAI 8/10

Why Concentrix Stock Ended Up Moving Higher Today

Concentrix (CNXC) reported fiscal Q3 revenue below estimates due to client shifts, but earnings beat expectations. CEO Christopher Caldwell attributed the shortfall to client preferences, not customer loss. The stock initially dropped but recovered, up 3% by midday. Analysts' average price target is $33.50, over 30% above current levels.

aol.com3 min
SEP 30
$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

cnbc.com2 min
SEP 30
$CNXCLow

Why Concentrix (CNXC) Stock Is Up Today

Concentrix (CNXC) stock rose 4% after reporting a Q3 net loss of $988.1M, driven by a $1.5B goodwill impairment charge. Revenue fell 1.2% YoY to $2.45B, missing estimates. Adjusted EPS was $2.92. The company cited AI deployments and client decisions for the decline. Shares later cooled to $25.73, up 1%.

stockstory.org2 min